Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab + FOLFOXIRI/Bevacizumab in mCRC
NCT04072198Phase 2Completed
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Start
- Sep 2019
- Primary completion
- Aug 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in metastatic colorectal cancer (mCRC), sponsored by Gruppo Oncologico Italiano di Ricerca Clinica. Started Sep 2019; status: completed.
02
Drugs
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT04072198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072198.